Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-01-09 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Parties | JANSSEN RESEARCH AND DEVELOPMENT LLC | ||
Patents | 6,414,126; 6,515,117; 7,943,582; 8,513,202 | ||
Attorneys | AMY DANIELLE LURIA | ||
Firms | Quinn Emanuel Urquhart & Sullivan, LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED
Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
0000-00-00 | 1 | JP) 6,414,126 B1 7/2002 Ellsworth et a1. …characteristics, is characterized by its 6,414,126 B1 7/2002 Ellsworth et al. …United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively… claim of the ’582 patent or ’202 patent other than for claim 7 of the ’582 patent and claim 4 of the… claim of the ’582 patent or ’202 patent other than for claim 7 of the ’582 patent and claim 4 of the | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |